NEKTAR THERAPEUTICS (NKTR) Stock Cash Flow
NASDAQ:NKTR - US6402681083 - Common Stock
27.03 USD
-0.97 (-3.46%)
27.2 USD
+0.17 (+0.63%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -122.27M | -118.96M | -276.06M | -368.20M | -523.80M | |||
| Depreciation Amortization | 1.97M | 4.39M | 7.82M | 13.00M | 14.10M | |||
| Income Taxes - Deferred | N/A | N/A | -140.00K | 2.70M | N/A | |||
| Change In Working Capital | -14.15M | -6.24M | -19.80M | 500.00K | -23.10M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 76.00K | 2.66M | 300.00K | 300.00K | |||
| Other non cash items | -50.44M | -54.90M | 95.58M | 48.00M | 120.10M | |||
| OPERATING CASH FLOW | -184.91M | -175.71M | -192.61M | -304.00M | -412.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.16M | -1.47M | -865.00K | -5.70M | -15.00M | |||
| Other Investing Activity | 200.80M | 144.04M | 140.43M | 371.50M | 217.80M | |||
| INVESTING CASH FLOW | 199.63M | 142.57M | 139.56M | 365.80M | 202.80M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 314.00K | 27.12M | 30.00K | 800.00K | 33.20M | |||
| Other Financing Activity | 0.00 | 15.00M | 0.00 | 800.00K | 3.00M | |||
| FINANCING CASH FLOW | 314.00K | 42.12M | 30.00K | 1.50M | 36.20M | |||
| Exchange Rate Effect | 10.00K | -4.00K | 62.00K | -300.00K | -100.00K | |||
| CHANGE IN CASH | 15.05M | 8.97M | -52.95M | 63.00M | -173.80M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -184.91M | -175.71M | -192.61M | -304.00M | -412.70M | |||
| Capital Expenditure | -1.16M | -1.47M | -865.00K | -5.70M | -15.00M | |||
| FREE CASH FLOW | -186.07M | -177.18M | -193.47M | -309.70M | -427.70M | |||
All data in USD